Skip to main content
SpringerLink
Log in

Low incidence of invasive fungal infections after bone marrow transplantation in patients receiving amphotericin B inhalations during neutropenia

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Summary

The incidence of invasive fungal infections after bone marrow transplantation (BMT) was analyzed in 303 consecutive marrow graft recipients (allogeneicn=271, autologousn=27, syngeneicn=5). All patients received inhalations with amphotericin B (10 mg twice daily) during neutropenia. The overall incidence of invasive fungal infections within the first 120 days after transplant was 3.6% (11/303; aspergillosis: 6; yeast infection: 5). Four of the 11 cases occurred early, and seven cases were observed after neutrophil recovery and discontinuation of amphotericin B inhalation treatment. Late infection was significantly associated with the development of acute graft-versus-host disease. Four of the 11 infections (early 2/4; late: 2/7) were observed in patients with a history of previous fungal infection. Other patient and treatment characteristics were not helpful in defining potential risk factors. In particular, the incidence of invasive fungal infections did not differ between patients with more or less strict reverse isolation measures. Occasional side effects such as initial mild cough and bad taste were rare, usually disappeared during continued administration, and were in no case the reason for discontinuation of treatment. These data suggest that aerosolized amphotericin B may be a useful, convenient, and efficient prophylactic antifungal regimen in BMT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Beyer J, Barzen G, Risse G, Weyer C, Miksits K, Dullenkopf K, Huhn D, Siegert W (1993) Aerosol amphotericin B for prevention of invasive pulmonary aspergillosis. Antimicrob Agents Chemother 37:1367–1369

    PubMed  Google Scholar 

  2. Conneally E, Cafferky MT, Daly PA, Keane CT, McCann SR (1990) Nebulized amphotericin B as prophylaxis against invasive aspergillosis in granulocytopenic patients. Bone Marrow Transplant 5:403–406

    PubMed  Google Scholar 

  3. Denning DW, Donnelly JP, Hellreigel KP, Ito J, Martino P, van't Wout JW (1992) Antifungal prophylaxis during neutropenia or allogeneic bone marrow transplantation: What is the state of the art? Chemotherapy 38 [Suppl 1]:43–49

    PubMed  Google Scholar 

  4. Goodman JL, Winston DJ, Greenfield RA, Chandrasekar PH, Fox B, Kaizer H, Shadduck RK, Shea TC, Stiff P, Friedman DJ, Powderly WG, Silber J, Horowitz H, Lichtin A, Wolff SN, Mangan KF, Silver SM, Weisdorf D, Ho WG, Gilbert G, Buell D (1992) A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 326:845–851

    PubMed  Google Scholar 

  5. Goodrich JM, Reed EC, Mori M, Fisher LD, Skerrett S, Dandliker PS, Klis B, Counts GW, Meyers JD (1991) Clinical features and analysis of risk factors for invasive candidal infection after marrow transplantation. J Infect Dis 164:731–740

    PubMed  Google Scholar 

  6. Jeffery GM, Beard MEJ, Ikram RB, Chua J, Allen JR, Heaton DC, Hart DNJ, Schousboe MI (1991) Intranasal amphotericin B reduces the frequency of invasive aspergillosis in neutropenic patients. Am J Med 90:685–692

    PubMed  Google Scholar 

  7. Jorgensen C, Dreyfus F, Vaixeler F, Guyomard S, Belanger C, Brunet F, Giraud T, Dupuis-Camay P (1989) Failure of amphotericin B spray to prevent aspergillosis in granulocytopenic patients. Nouv Rev Fr Hematol 31:327–328

    PubMed  Google Scholar 

  8. Kreisel W, Köchling G, Schilling CV, Azemar M, Kurzweil B, Dölken G, Lindemann A, Blum U, Windfuhr M, Müller J (1991) Therapy of invasive aspergillosis with itraconazole: improvement of therapeutic efficacy by early diagnosis. Mycoses 34:385–394

    PubMed  Google Scholar 

  9. Lennette FN, Balows A, Hausler WJ, Shadomy NJ (1985) Manual of clinical microbiology. American Society for Microbiology, Washington DC

    Google Scholar 

  10. Lentino JR, Rosenkranz MA, Michaelis JA, Kurup VP, Rose HD, Rytel MW (1982) Nosocomial aspergillosis. A retrospective review of airborne disease secondary to road construction and contaminated air conditioners. Am J Epidemiol 116:430–437

    PubMed  Google Scholar 

  11. Meunier F, Leleux A, Snoeck R, Gerain J, Lambert C, Ceuppens AM (1989) Chemoprophylaxis of fungal infections. In: Holmberg K, Meyer RD (eds) Diagnosis and therapy of systemic fungal infections. Raven, New York, pp 167–177

    Google Scholar 

  12. Meunier-Carpentier F, Snoeck R, Gerain J, Muller C, Klastersky J (1984) Amphotericin B nasal spray as prophylaxis against aspergillosis in patients with neutropenia. N Engl J Med 311:1056

    Google Scholar 

  13. Meyers JD (1990) Fungal infections in bone marrow transplant patients. Semin Oncol 17 [Suppl 6]:10–13

    Google Scholar 

  14. Myers SE, Devine SM, Topper RL, Ondrey M, Ramming K, Chandler C, Williams SF, Larson RA, Geller RB (1992) A phase-I trial of prophylactic aerosolized amphotericin B in patients at risk for prolonged neutropenia. Leuk Lymphoma 8:229–233

    PubMed  Google Scholar 

  15. Oehling A, Giron M, Subira ML (1975) Aerosol chemotherapy in bronchopulmonary candidiasis. Respiration 32:179–184

    PubMed  Google Scholar 

  16. Opal SM, Asp AA, Cannady PB, Morse PL, Burton LJ, Hammer PG (1986) Efficacy of infection control measures during a nosocomial outbreak of disseminated aspergillosis associated with hospital construction. J Infect Dis 153:634–637

    PubMed  Google Scholar 

  17. Pannuti CS, Gingrich RD, Pfaller MA, Wenzel RP (1991) Nosocomial pneumonia in adult patients undergoing bone marrow transplantation: a 9-year study. J Clin Oncol 9:77–84

    PubMed  Google Scholar 

  18. Perfect JR, Klotman ME, Gilbert CC, Crawford DD, Rosner GL, Wright KA, Peters WP (1992) Prophylactic intravenous amphotericin B in neutropenic autologous bone marrow transplant recipients. J Infect Dis 165:891–897

    PubMed  Google Scholar 

  19. Pirsch JD, Maki DG (1986) Infections complications in adult bone marrow transplantation and T-cell depletion of donor marrow. Increased susceptibility to fungal infections. Ann Intern Med 104:619–631

    PubMed  Google Scholar 

  20. Robertson MJ, Larson RA (1988) Recurrent fungal pneumonias in patients with acute nonlymphocytic leukemia undergoing multiple courses of intensive chemotherapy. Am J Med 84:233–239

    PubMed  Google Scholar 

  21. Rousey SR, Russler S, Gottlieb M, Ash RC (1991) Low-dose amphotericin B prophylaxis against invasiveAspergillus infections in allogeneic marrow transplantation. Am J Med 91:484–492

    PubMed  Google Scholar 

  22. Schmitt HJ, Bernard EM, Häuser M, Armstrong D (1988) Aerosol amphotericin B is effective for prophylaxis and therapy in a rat model of pulmonary aspergillosis. Antimicrob Agents Chemother 32:1676–1679

    PubMed  Google Scholar 

  23. Sherertz RJ, Belani A, Kramer BS, Elfenbein G, Weiner RS, Sullivan ML, Thomas RG, Samsa GP (1987) Impact of air filtration on nosocomialAspergillus infections. Unique risk of bone marrow transplant recipients. Am J Med 83:709–718

    PubMed  Google Scholar 

  24. Skobel P (1966) Zum Problem pilzbedingter Superinfektionen der Atemorgane sowie deren Behandlung mit Inhalationen und Installationen von Amphotericin B und Moronal Reinsubstanz. Med Welt 17:2755–2759

    Google Scholar 

  25. Tollemar J, Ringden O, Bostrom L, Nilsson B, Sundberg B (1989) Variables predicting deep fungal infections in bone marrow transplant recipients. Bone Marrow Transplant 4:635–641

    PubMed  Google Scholar 

  26. Verfaillie C, Weisdorf D, Haake R, Hostetter M, Ramsay NK, McGlave P (1991)Candida infections in bone marrow transplant recipients. Bone Marrow Transplant 8:177–184

    PubMed  Google Scholar 

  27. Wingard JR, Beals SU, Santos GW, Merz WG, Saral R (1987)Aspergillus infections in bone marrow transplant recipients. Bone Marrow Transplant 2:175–181

    PubMed  Google Scholar 

  28. Wingard JR, Merz WG, Rinaldi MG, Johnson TR, Karp JE, Saral R (1991) Increase inCandida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 325:1274–1277

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology - Oncology and Section of Infectious Diseases and Clinical Immunology, Ulm University Hospital, D-89070, Ulm, Germany

    B. Hertenstein, W. V. Kern, T. Schmeiser, M. Stefanic, D. Bunjes, M. Wiesneth, J. Novotny, H. Heimpel & R. Arnold

Authors
  1. B. Hertenstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. V. Kern
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. Schmeiser
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Stefanic
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D. Bunjes
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. Wiesneth
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. J. Novotny
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. H. Heimpel
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. R. Arnold
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hertenstein, B., Kern, W.V., Schmeiser, T. et al. Low incidence of invasive fungal infections after bone marrow transplantation in patients receiving amphotericin B inhalations during neutropenia. Ann Hematol 68, 21–26 (1994). https://doi.org/10.1007/BF01695915

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01695915

Key words

Search

Navigation